1. Home
  2. CHRO vs DGLY Comparison

CHRO vs DGLY Comparison

Compare CHRO & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • DGLY
  • Stock Information
  • Founded
  • CHRO 2002
  • DGLY 2004
  • Country
  • CHRO United States
  • DGLY United States
  • Employees
  • CHRO N/A
  • DGLY N/A
  • Industry
  • CHRO
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CHRO
  • DGLY Technology
  • Exchange
  • CHRO Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • CHRO 3.9M
  • DGLY 3.8M
  • IPO Year
  • CHRO 2024
  • DGLY N/A
  • Fundamental
  • Price
  • CHRO $0.66
  • DGLY $0.58
  • Analyst Decision
  • CHRO Strong Buy
  • DGLY
  • Analyst Count
  • CHRO 1
  • DGLY 0
  • Target Price
  • CHRO N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • CHRO 100.6K
  • DGLY 101.7K
  • Earning Date
  • CHRO 11-13-2024
  • DGLY 11-29-2024
  • Dividend Yield
  • CHRO N/A
  • DGLY N/A
  • EPS Growth
  • CHRO N/A
  • DGLY N/A
  • EPS
  • CHRO N/A
  • DGLY N/A
  • Revenue
  • CHRO N/A
  • DGLY $23,417,110.00
  • Revenue This Year
  • CHRO N/A
  • DGLY $22.14
  • Revenue Next Year
  • CHRO N/A
  • DGLY N/A
  • P/E Ratio
  • CHRO N/A
  • DGLY N/A
  • Revenue Growth
  • CHRO N/A
  • DGLY N/A
  • 52 Week Low
  • CHRO $0.52
  • DGLY $0.56
  • 52 Week High
  • CHRO $6.00
  • DGLY $3.29
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 48.22
  • DGLY 26.43
  • Support Level
  • CHRO $0.63
  • DGLY $1.01
  • Resistance Level
  • CHRO $0.69
  • DGLY $1.19
  • Average True Range (ATR)
  • CHRO 0.06
  • DGLY 0.10
  • MACD
  • CHRO 0.01
  • DGLY -0.04
  • Stochastic Oscillator
  • CHRO 52.55
  • DGLY 2.35

About CHRO Chromocell Therapeutics Corporation

Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain and other associated medical conditions. The company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic neuropathic pain and eye pain. The Company's portfolio also includes pre-clinical work on other sodium channel receptor subtypes, and the company intends to explore these and other compounds for the treatment of additional pain indications.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: